fibrinolysins activate
fibrinolysiner aktiveres
administering fibrinolysins
administrere fibrinolysiner
fibrinolysin levels
fibrinolysin niveauer
measuring fibrinolysins
måle fibrinolysiner
fibrinolysin treatment
fibrinolysinbehandling
inhibiting fibrinolysins
inhibere fibrinolysiner
fibrinolysins degrade
fibrinolysiner nedbrydes
detecting fibrinolysins
detektere fibrinolysiner
fibrinolysin activity
fibrinolysinaktivitet
increased fibrinolysins
øget fibrinolysin
researchers are investigating the potential of fibrinolysins for treating ischemic stroke.
Forskerne undersøger potentialet for fibrinolysiner til behandling af iskæmisk slaganfall.
fibrinolysins can effectively dissolve blood clots in the circulatory system.
Fibrinolysiner kan effektivt opløse blodpropper i kredsløbet.
the development of novel fibrinolysins is a key area of pharmaceutical research.
Udviklingen af nye fibrinolysiner er en vigtig område i farmaceutisk forskning.
administering fibrinolysins requires careful monitoring of patient coagulation status.
At give fibrinolysiner kræver omhyggelig overvågning af patientens koagulationsstatus.
engineered fibrinolysins offer improved efficacy and reduced bleeding risks.
Ingeniørens fibrinolysiner tilbyder forbedret effektivitet og reduceret blødningsrisiko.
fibrinolysins' mechanism of action involves the breakdown of fibrin networks.
Mekanismen for virkning af fibrinolysiner involverer nedbrydning af fibrinnetværk.
clinical trials are evaluating the safety and efficacy of recombinant fibrinolysins.
Kliniske prøver vurderer sikkerheden og effektiviteten af rekombinerede fibrinolysiner.
the rapid onset of action is a significant advantage of certain fibrinolysins.
Den hurtige virkningstid er en betydelig fordel for visse fibrinolysiner.
understanding fibrinolysins' interactions with other clotting factors is crucial.
At forstå interaktionen mellem fibrinolysiner og andre koagulationsfaktorer er afgørende.
fibrinolysins are being explored as a potential treatment for deep vein thrombosis.
Fibrinolysiner undersøges som en potentiel behandling for dyb vene trombose.
the stability of fibrinolysins in storage is an important consideration for manufacturers.
Stabiliteten af fibrinolysiner under opbevaring er en vigtig overvejelse for producenter.
fibrinolysins activate
fibrinolysiner aktiveres
administering fibrinolysins
administrere fibrinolysiner
fibrinolysin levels
fibrinolysin niveauer
measuring fibrinolysins
måle fibrinolysiner
fibrinolysin treatment
fibrinolysinbehandling
inhibiting fibrinolysins
inhibere fibrinolysiner
fibrinolysins degrade
fibrinolysiner nedbrydes
detecting fibrinolysins
detektere fibrinolysiner
fibrinolysin activity
fibrinolysinaktivitet
increased fibrinolysins
øget fibrinolysin
researchers are investigating the potential of fibrinolysins for treating ischemic stroke.
Forskerne undersøger potentialet for fibrinolysiner til behandling af iskæmisk slaganfall.
fibrinolysins can effectively dissolve blood clots in the circulatory system.
Fibrinolysiner kan effektivt opløse blodpropper i kredsløbet.
the development of novel fibrinolysins is a key area of pharmaceutical research.
Udviklingen af nye fibrinolysiner er en vigtig område i farmaceutisk forskning.
administering fibrinolysins requires careful monitoring of patient coagulation status.
At give fibrinolysiner kræver omhyggelig overvågning af patientens koagulationsstatus.
engineered fibrinolysins offer improved efficacy and reduced bleeding risks.
Ingeniørens fibrinolysiner tilbyder forbedret effektivitet og reduceret blødningsrisiko.
fibrinolysins' mechanism of action involves the breakdown of fibrin networks.
Mekanismen for virkning af fibrinolysiner involverer nedbrydning af fibrinnetværk.
clinical trials are evaluating the safety and efficacy of recombinant fibrinolysins.
Kliniske prøver vurderer sikkerheden og effektiviteten af rekombinerede fibrinolysiner.
the rapid onset of action is a significant advantage of certain fibrinolysins.
Den hurtige virkningstid er en betydelig fordel for visse fibrinolysiner.
understanding fibrinolysins' interactions with other clotting factors is crucial.
At forstå interaktionen mellem fibrinolysiner og andre koagulationsfaktorer er afgørende.
fibrinolysins are being explored as a potential treatment for deep vein thrombosis.
Fibrinolysiner undersøges som en potentiel behandling for dyb vene trombose.
the stability of fibrinolysins in storage is an important consideration for manufacturers.
Stabiliteten af fibrinolysiner under opbevaring er en vigtig overvejelse for producenter.
Explore frequently searched vocabulary
Want to learn vocabulary more efficiently? Download the DictoGo app and enjoy more vocabulary memorization and review features!
Download DictoGo Now